期刊文献+

人巨细胞病毒糖蛋白gB基因重组腺病毒载体的构建及包装 被引量:2

Construction and Packaging of Recombinant Adenovirus Vector Carrying gB Gene of Human Cytomegalovirus
下载PDF
导出
摘要 目的构建携带有人巨细胞病毒(HCMV)糖蛋白gB基因的重组腺病毒载体,并在HEK293细胞中进行包装。方法将gB基因克隆至穿梭质粒Track-CMV,构建重组质粒Track-CMV/gB,亚克隆至转移载体pAD-Easy-1,构建重组质粒pAD-Easy-1/gB,将该重组骨架质粒转染HEK293细胞,利用HEK293细胞产生重组腺病毒。空斑法及PCR法挑选重组病毒,荧光显微镜观察标志蛋白(绿色荧光蛋白)的表达,利用噬斑法检测病毒滴度。结果重组腺病毒载体经酶切鉴定证明构建正确,转染重组腺病毒载体的HEK293细胞经PCR扩增,可见约700bp的目的基因片段,荧光显微镜观察可见绿色荧光蛋白表达,空斑试验检测病毒滴度为2×106PFU/ml。结论已成功构建了含有gB基因的重组腺病毒载体,为进一步研制重组腺病毒载体HCMV疫苗提供了条件。 Objective To construct the recombinant adenovirus vector carrying gB gene of human cytomegalovirus (HCMV) for packaging in HEK293 cells. Methods Clone gB gene to shuttle plasmid Track-CMV, then co-transform adenovirus skeleton plasmid pAD-Easy-1 and the constructed recombinant plasmid Traek-CMV/gB to E. coli BJ5183 cells. Screen positive clones, extract recombinant plasmid pAD-Easy-1/gB and transfeet to HEK293 cells. Recombinant adenovirus was screened by plaque formation test and PCR, observed for the expression of green fluorescence protein (GFP) as marker by fluorescent microscopy, and determined for titer by plaque assay. Results Restriction analysis proved that recombinant adenovirus vector was constructed correctly. The target gene fragment at a length of about 700 bp was amplified by PCR from the HEK293 cells transfected with pAD-Easy-1/gB. Fluorescent microscopy proved the expression of GFP, The titer of recombinant adenovirus was 2 × 10^6 PFU/ml, Conclusion The recombinant adenovirus carrying gB gene of HCMV was successfully constructed, which provided a basis for further preparation of recombinant adenovirus-based HCMV vaccine,
出处 《中国生物制品学杂志》 CAS CSCD 2008年第7期575-578,共4页 Chinese Journal of Biologicals
关键词 人巨细胞病毒 糖蛋白gB基因 腺病毒载体 构建 包装 Human cytomegalovirus (HCMV) Glycoprotein gB gene Adenovirus vector Constrution Packaging
  • 相关文献

参考文献11

  • 1Britt WJ, Alford CA. Cytomegalovirus. Infields Virology. 3rd ed. Philadelphia: Lippineott-Raven, 1996. 2493-2523. 被引量:1
  • 2Alba R, Bosch A, Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther, 2005 ( 12 suppl 1 ): s18-s27. 被引量:1
  • 3Stone D, Ni S, Li ZY, et al. Development and assessment of human adenovirus type Ⅱ as a gene transfer vector. J Vriol, 2005, 79 (8): 5090-5104. 被引量:1
  • 4Gonczol E, Plotkin S.Development of cytomegalovirus vaccine: lessons from recent clinical trials. Expert Opin Biol Ther, 2001, 1 (3): 401-412. 被引量:1
  • 5Giffiths PD, McLean A, Emery VC. Encouaging prospects for immunization against primary cytomegalovirs infection. Vaccine, 2001, 19( 11-12 ): 1356-1362. 被引量:1
  • 6Plostine SA. Cytomegalovirus vaccine. Am Heart J, 1999, 138 (5pt2): s484-s487. 被引量:1
  • 7Barajas M,Mazzolini G, Genove G, et al. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin12. Hepatology, 2001, 33( 1 ): 52-61. 被引量:1
  • 8罗凌惠,龚树生,宋鹏,鄢开胜,刘英鹏.人Bcl-2基因重组腺病毒的构建及其在螺旋神经节细胞中的表达[J].中华耳鼻咽喉头颈外科杂志,2005,40(7):513-516. 被引量:5
  • 9刘斌剑,王建民,陈林,宋瑞华,赵玲,宋维威,苟元彬.Bek腺病毒表达载体的构建及其在哺乳类动物细胞中的表达[J].第三军医大学学报,2006,28(2):144-146. 被引量:2
  • 10顾健人,曹雪涛主编..基因治疗[M].北京:科学出版社,2001:314.

二级参考文献22

  • 1ORNITZ D M,ITOH N.Fibroblast growth factors[J].Genome Biol,2001,2(3):reviews 3005. 被引量:1
  • 2HE T C,ZHOU S,DA COSTA L T,et al.A simplified system for generating recombinant adenoviruses[J].Proc Natl Acad Sci U S A,1998,95(5):2509-2514. 被引量:1
  • 3NASKI M C,ORNITZ D M.FGF signaling in skeletal development[J].Front Biosci,1998,3:D781 -D794. 被引量:1
  • 4GILBERT E,DEL GATTO F,CHAMPION ARNAUD P,et al.Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA[J].Mol Cell Biol,1993,13(9):5461 -5468. 被引量:1
  • 5YU K,XU J,LIU Z,et al.Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth[J].Development,2003,130 (13):3063-3074. 被引量:1
  • 6ORNITZ D M,XU J,COLVIN J S,et al.Receptor specificity of the fibroblast growth factor family[J].J Biol Chem,1996,271 (25):15292-15297. 被引量:1
  • 7ORR URTREGER A,BEDFORD M T,BURAKOVA T,et al.Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)[J].Dev Biol,1993,158(2):475 -486. 被引量:1
  • 8Alam SA,Oshima T,Suzuki M,et al.The expression of apoptosis-related proteins in the aged cochlea of Mongolian gerbils. Laryngoscope,2001,111:528-534. 被引量:1
  • 9Alam SA,Ikeda K,Oshima T, et al. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea.Hear Res,2000,141:28-38. 被引量:1
  • 10Zhao H,Yenari MA,Cheng D, et al.Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity.J Neurochem,2003,85:1026-1036. 被引量:1

共引文献5

同被引文献19

  • 1罗满林.猪细胞巨化病毒感染研究进展[J].中国兽医杂志,2004,40(8):34-37. 被引量:10
  • 2Krause,DS,Van,Etten,RA,黄艳.癌症治疗的靶点——酪氨酸激酶[J].中国处方药,2005(10):33-36. 被引量:45
  • 3斯特劳BE,阿莱尔S D,蒙加林W L,等.赵德明,张中秋,沈建忠主译.猪病学[M].第8版.北京:中国农业大学出版社,2000,357-367. 被引量:15
  • 4Andre L H, Lin L H. PCR assay for detecting porcine eytomega lovirus[J]. Journal of Clinical Microbiology, 1999, 37 ( 11 ) 3767-3768. 被引量:1
  • 5Assa R,13ouiLant A M,Franeo E D,et at. Enzyme Linked immunosorbent assay (EI.ISA) {or the detection of antibodies to por- cine cytomegalovirus[J]. Can Comp Med, 1982,46 (2) : 183 185. 被引量:1
  • 6Booth J C, Goodwin R E, Whittlestone P. Inclusion-body rhinitis of pigs:Attempts to grow the causal agent in tissue cultures[J]. Res Vet Sci, 1967(8):338-345. 被引量:1
  • 7Britt W J, Mach M. Human cytomegalovirus glyeoproteins[J]. Intervirology, 1996,39 (5 - 6) :401-412. 被引量:1
  • 8Cameronstephen I D. Inclusion-body rhinitis of swine[J]. Aust Vet J,1961,37:87-91. 被引量:1
  • 9Done J T, An"inclusion body"rhinitis of pigs[J], Vet Rec, 1955, 67:525-527. 被引量:1
  • 10Fryer J F, Griffiths P D, Fishman J A,et al. Quantitafion of por- cine cytomegaiovirus in pig tissues lay PCR[J]. Journal of Clinical Microbiology, 2001,3 - 1155- 1156. 被引量:1

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部